RBC Europe’s Exact Sciences EXAS Stock Holding History

RBC Europe’s Portfolio EXAS Stock Details EXAS Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q2	$20K	Sell	500 -100	-17%	-$5.35K	﹤0.01%	423
2022 Q1	$42K	Sell	600 -100	-14%	-$7.31K	﹤0.01%	372
2021 Q4	$54K	Hold	700	–	–	﹤0.01%	353
2021 Q3	$66.8K	Hold	700	–	–	﹤0.01%	514
2021 Q2	$87K	Hold	700	–	–	﹤0.01%	461
2021 Q1	$92.2K	Sell	700 -735	-51%	-$101K	0.01%	422
2020 Q4	$190K	Hold	1,435	–	–	0.01%	294
2020 Q3	$146K	Sell	1,435 -575	-29%	-$49.7K	0.01%	298
2020 Q2	$175K	Sell	2,010 -106	-5%	-$8.47K	0.01%	260
2020 Q1	$123K	Hold	2,116	–	–	0.01%	267
2019 Q4	$196K	Buy	2,116 +866	+69%	+$76.1K	0.02%	253
2019 Q3	$113K	Hold	1,250	–	–	0.01%	311
2019 Q2	$148K	Hold	1,250	–	–	0.01%	282
2019 Q1	$108K	Hold	1,250	–	–	0.01%	318
2018 Q4	$78.9K	Sell	1,250 -660	-35%	-$45.3K	0.01%	349
2018 Q3	$151K	Hold	1,910	–	–	0.02%	285
2018 Q2	$114K	Hold	1,910	–	–	0.01%	334
2018 Q1	$77K	Hold	1,910	–	–	0.01%	390
2017 Q4	$100K	Hold	1,910	–	–	0.01%	350
2017 Q3	$90K	Buy	+1,910	New	+$76.9K	0.01%	375

Other funds holding EXAS

AIM

ARK Investment Management St. Petersburg, Florida $12.9B AUM 64.92% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return

Sumitomo Mitsui Trust Group Minato-Ku, Tokyo, Japan $175B AUM 40.63% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

NAMA

Nikko Asset Management Americas New York $7.07B AUM 50.91% 1-Year Est. Return

RBC Europe's EXAS Position: Q2 2022 in Review

RBC Europe reduced its Exact Sciences (EXAS) stake by 17% in Q2 2022, selling an estimated $5.35K and leaving 500 shares worth $20K. The position accounts for ﹤0.01% of the portfolio, ranked #423.

RBC Europe first reported a position in EXAS in Q3 2017 and has held it in 20 quarters since. The position peaked at $196K in Q4 2019. 501 funds tracked by Wall St. Rank hold EXAS as of Q2 2022.

RBC Europe held 500 shares of Exact Sciences worth $20K as of Q2 2022.
RBC Europe sold 100 Exact Sciences shares in Q2 2022, an estimated $5.35K.
Exact Sciences made up ﹤0.01% of RBC Europe's portfolio in Q2 2022, its #423 holding.
RBC Europe first reported a position in Exact Sciences in Q3 2017 and has held it in 20 quarters since.
RBC Europe's Exact Sciences position peaked at $196K in Q4 2019.
501 funds tracked by Wall St. Rank held Exact Sciences as of Q2 2022.

Based on RBC Europe's 13F filing for Q2 2022, filed 14 Nov 2022.